- Home
- MBLY vs ARWR Comparison
MBLY vs ARWR Comparison
Compare MBLY & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBLY | ARWR |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 10.1B |
| IPO Year | 2022 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MBLY | ARWR |
|---|---|---|
| Price | $7.85 | $58.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 10 |
| Target Price | $16.17 | ★ $81.50 |
| AVG Volume (30 Days) | ★ 4.0M | 1.9M |
| Earning Date | 04-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 87.43 | ★ 99.80 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $1,894,000,000.00 | $16,142,321.00 |
| Revenue This Year | $4.91 | N/A |
| Revenue Next Year | $14.09 | N/A |
| P/E Ratio | ★ N/A | $263.64 |
| Revenue Growth | ★ 14.51 | N/A |
| 52 Week Low | $7.71 | $10.66 |
| 52 Week High | $20.18 | $76.76 |
Technical Indicators
Market Signals| Indicator | MBLY | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 29.25 | 36.19 |
| Support Level | N/A | $36.34 |
| Resistance Level | $9.74 | $66.37 |
| Average True Range (ATR) | 0.29 | 3.00 |
| MACD | -0.02 | -0.49 |
| Stochastic Oscillator | 8.58 | 13.32 |
Price Performance
Historical ComparisonAbout MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Moovit. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.